Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovate (VATE) Cash & Equivalents (2016 - 2025)

Innovate (VATE) has 16 years of Cash & Equivalents data on record, last reported at $35.5 million in Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 30.39% year-over-year to $35.5 million; the TTM value through Sep 2025 reached $35.5 million, down 30.39%, while the annual FY2024 figure was $48.8 million, 39.6% down from the prior year.
  • Cash & Equivalents reached $35.5 million in Q3 2025 per VATE's latest filing, up from $33.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $80.8 million in Q4 2023 and bottomed at $16.6 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $43.9 million, with a median of $38.4 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 263.76% in 2021, then tumbled 58.35% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $45.5 million in 2021, then soared by 76.7% to $80.4 million in 2022, then grew by 0.5% to $80.8 million in 2023, then plummeted by 39.6% to $48.8 million in 2024, then fell by 27.25% to $35.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $35.5 million in Q3 2025, $33.4 million in Q2 2025, and $33.3 million in Q1 2025.